Aggravated airway inflammation: research on genomics and optimal treatments

  • Toppila-Salmi, Sanna Katriina (Project manager)
  • Kauppi, Paula (Participant)
  • Laulajainen-Hongisto, Anu (Participant)
  • Hammaren-Malmi, Sari (Principal investigator)
  • Hafren, Lena (Participant)
  • Mäkelä, Mika Juhani (Participant)
  • Mäkitie, Antti Aarni (Participant)
  • Fokkens, Wytske (Participant)
  • Reitsma, Sietze (Participant)
  • Sillanpää, Saara (Participant)
  • Karjalainen, Jussi (Participant)
  • Sahlman, Johanna (Participant)
  • Kiviranta, Jukka (Participant)
  • Halme, Perttu (Participant)
  • Kilpeläinen, Maritta (Participant)
  • Alakärppä, Antti (Participant)
  • Tiitto, Leena (Participant)
  • Virkkula, Paula Maarit (Project manager)

Description

This is a randomized controlled multicenter study that focuses on severe CRSwNP ± asthma ±AERD. The clinical significance of this study is to develop cost-effective treatment models that will facilitate risk-estimation and prevention of the onset and the progression of severe CRSwNP, asthma and AERD.
AcronymAirGOs-Oper, AirGOs-Medical
StatusActive
Effective start/end date01/05/2018 → …